Pharmacokinetics of N,N-dimethyltryptamine in Humans-Reference-Cited by-同舟云学术

Pharmacokinetics of N,N-dimethyltryptamine in Humans

Published:2023-04-22 Issue:3 Volume:48 Page:311-327
ISSN:0378-7966
Container-title:European Journal of Drug Metabolism and Pharmacokinetics
language:en
Short-container-title:Eur J Drug Metab Pharmacokinet

Author:

Good Meghan^ORCID,Joel Zelah,Benway Tiffanie,Routledge Carol,Timmermann Chris,Erritzoe David,Weaver Richard,Allen Graham,Hughes Charlotte,Topping Helen,Bowman Amy,James Ellen

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Link

https://link.springer.com/content/pdf/10.1007/s13318-023-00822-y.pdf

Reference46 articles.

1. Carhart-Harris RL, Bolstridge M, Day CMJ, Rucker J, Watts R, Erritzoe DE, et al. Psilocybin with psychological support for treatment-resistant depression: six-month follow-up. Psychopharmacology. 2018;235(2):399–408.

2. Carhart-Harris RGB, Watts R, Baker-Jones M, Murphy-Beiner A, Murphy R, Martell J, Blemings A, Erritzoe D, Nutt DJ. Trial of psilocybin versus escitalopram for depression. N Engl J Med. 2021;384:1402–11.

3. Sanches RF, de Lima OF, Dos Santos RG, Macedo LR, Maia-de-Oliveira JP, Wichert-Ana L, et al. antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a SPECT study. J Clin Psychopharmacol. 2016;36(1):77–81.

4. Palhano-Fontes F, Barreto D, Onias H, Andrade KC, Novaes MM, Pessoa JA, et al. Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial. Psychol Med. 2019;49(4):655–63.

5. Carhart-Harris RL, Muthukumaraswamy S, Roseman L, Kaelen M, Droog W, Murphy K, et al. Neural correlates of the LSD experience revealed by multimodal neuroimaging. Proc Natl Acad Sci U S A. 2016;113(17):4853–8.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neurobiological research on N,N-dimethyltryptamine (DMT) and its potentiation by monoamine oxidase (MAO) inhibition: from ayahuasca to synthetic combinations of DMT and MAO inhibitors;Cellular and Molecular Life Sciences;2024-09-10

2. Metabolism and cytotoxicity studies of the two hallucinogens 1cP-LSD and 4-AcO-DET in human liver and zebrafish larvae models using LC-HRMS/MS and a high-content screening assay;Journal of Pharmaceutical and Biomedical Analysis;2024-08

3. Novel extended-release transdermal formulations of the psychedelic N,N-dimethyltryptamine (DMT);European Journal of Pharmaceutical Sciences;2024-08

4. Novel Thermosensitive and Mucoadhesive Nasal Hydrogel Containing 5-MeO-DMT Optimized Using Box-Behnken Experimental Design;Polymers;2024-07-29

5. Psychedelics in developmental stuttering to modulate brain functioning: a new therapeutic perspective?;Frontiers in Human Neuroscience;2024-06-19